Koninklijke Philips N.V. (NYSE:PHG) Stock Rated "Hold" by Wall Street Analysts

Key Points

• Wall Street consensus is “Hold”: All five analysts covering Koninklijke Philips rate the stock Hold, with UBS maintaining Neutral, Weiss Ratings downgrading its Hold score, and Zacks Research upgrading the shares from Strong Sell to Hold.
• Recent earnings exceeded expectations: Philips reported quarterly EPS of $0.57 versus the $0.40 consensus estimate and revenue of $4.98 billion, although revenue declined 3% year over year.
• Shares remain near the lower end of their annual range: PHG traded at $25.75, compared with a 12-month range of $23.62 to $33.44. Institutional investors own 13.67% of the company.

Shares of Koninklijke Philips N.V. (NYSE:PHG - Get Free Report) have earned a consensus recommendation of "Hold" from the five analysts that are covering the company, MarketBeat Ratings reports. Five analysts have rated the stock with a hold recommendation.

Several research firms have weighed in on PHG. Weiss Ratings cut Koninklijke Philips from a "hold (c+)" rating to a "hold (c)" rating in a report on Tuesday, October 6th. UBS Group restated a "neutral" rating on shares of Koninklijke Philips in a research report on Monday, August 3rd. Finally, Zacks Research raised shares of Koninklijke Philips from a "strong sell" rating to a "hold" rating in a research note on Thursday, August 13th.

Hedge Funds Weigh In On Koninklijke Philips

A number of institutional investors have recently made changes to their positions in PHG. Whipplewood Advisors LLC raised its position in shares of Koninklijke Philips by 923.7% during the 1st quarter. Whipplewood Advisors LLC now owns 993 shares of the technology company's stock valued at $27,000 after buying an additional 896 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new position in Koninklijke Philips in the second quarter worth $47,000. Bessemer Group Inc. grew its position in Koninklijke Philips by 19.8% in the first quarter. Bessemer Group Inc. now owns 2,756 shares of the technology company's stock worth $76,000 after acquiring an additional 456 shares in the last quarter. Parallel Advisors LLC increased its stake in Koninklijke Philips by 42.4% in the first quarter. Parallel Advisors LLC now owns 4,790 shares of the technology company's stock valued at $131,000 after acquiring an additional 1,427 shares during the last quarter. Finally, Global Assets Advisory LLC bought a new position in Koninklijke Philips in the first quarter valued at $161,000. Institutional investors own 13.67% of the company's stock.

Koninklijke Philips Price Performance

Shares of PHG stock traded up $0.26 on Friday, reaching $25.75. The company's stock had a trading volume of 1,338,634 shares, compared to its average volume of 1,151,310. The company has a market capitalization of $25.30 billion, a P/E ratio of 18.97, a PEG ratio of 10.59 and a beta of 0.77. Koninklijke Philips has a 12-month low of $23.62 and a 12-month high of $33.44. The stock's 50 day simple moving average is $25.62 and its 200-day simple moving average is $26.46. The company has a quick ratio of 0.82, a current ratio of 1.26 and a debt-to-equity ratio of 0.55.

Koninklijke Philips (NYSE:PHG - Get Free Report) last posted its earnings results on Monday, July 27th. The technology company reported $0.57 EPS for the quarter, topping the consensus estimate of $0.40 by $0.17. The business had revenue of $4.98 billion during the quarter, compared to analysts' expectations of $4.91 billion. Koninklijke Philips had a return on equity of 14.38% and a net margin of 6.30%. The firm's revenue was down 3.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.27 earnings per share. As a group, equities analysts predict that Koninklijke Philips will post 1.74 earnings per share for the current fiscal year.

About Koninklijke Philips

Koninklijke Philips N.V. is a Netherlands-based health technology company that develops products, services and software for healthcare providers, health systems and consumers. The company focuses on improving diagnosis, treatment and health management through connected technologies and data-enabled solutions.

Philips' healthcare portfolio includes diagnostic imaging systems such as magnetic resonance imaging, computed tomography and ultrasound equipment; image-guided therapy systems; patient monitoring and clinical informatics technologies; and solutions for sleep and respiratory care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.